Funded Tech Companies
AlveoGene
AlveoGene is a biopharmaceutical company, based in Oxford. Investment was provided by Oxford Science Enterprises, Harrington Discovery Institute at University Hospitals and Old College Capital.
Company Overview
Company Name
AlveoGene
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
46 Woodstock Rd
Oxford, OX2 6HT
UK
Oxford, OX2 6HT
UK
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
AlveoGene is an innovative company focused on transforming rare respiratory disease outcomes using inhaled gene therapy. AlveoGene has been created by OSE, Harrington and OCC in partnership with six leading scientists from the world-renowned UK Respiratory Gene Therapy Consortium (GTC). The GTC was founded in 2001 to catalyse the application of pioneering research to gene therapy development and manufacturing related to cystic fibrosis and other respiratory diseases, and originated at Imperial College London and the Universities of Oxford and Edinburgh.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/14/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Hipkiss
Co-Founder
Eric Alton
Company Investors
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs